Soluble receptor for AGE (RAGE) is a novel independent predictor of all-cause and cardiovascular mortality in type 1 diabetes (Q84183344)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21607631%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

title

Soluble receptor for AGE (RAGE) is a novel independent predictor of all-cause and cardiovascular mortality in type 1 diabetes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21607631%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21607631%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

author name string

J Söderlund

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21607631%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

M Lehto

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21607631%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

V-P Mäkinen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21607631%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

J L Moran

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21607631%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

M E Cooper

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21607631%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

C Forsblom

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21607631%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

P-H Groop

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21607631%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

FinnDiane Study Group

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21607631%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

publication date

24 May 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21607631%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21607631%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

volume

54

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21607631%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21607631%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

page(s)

2669-2677

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21607631%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00125-011-2186-5

2 February 2020

exact match

0 references

cites work

A strategy for modelling the effect of a continuous covariate in medicine and epidemiology.

1 reference

12 December 2020

Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men.

1 reference

12 December 2020

Serum levels of sRAGE, the soluble form of receptor for advanced glycation end products, are associated with inflammatory markers in patients with type 2 diabetes

1 reference

12 December 2020

The Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma2 gene is associated with plasma levels of soluble RAGE (Receptor for Advanced Glycation Endproducts) and the presence of peripheral arterial disease.

1 reference

12 December 2020

The valuable contribution of observational studies to nephrology

1 reference

12 December 2020

RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice.

1 reference

12 December 2020

Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab)

1 reference

12 December 2020

The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus

1 reference

12 December 2020

Advanced glycation end products: sparking the development of diabetic vascular injury

1 reference

12 December 2020

Severity of diabetic microvascular complications is associated with a low soluble RAGE level

1 reference

12 December 2020

Receptor for advanced glycation end products--soluble form and gene polymorphisms in chronic haemodialysis patients

1 reference

12 December 2020

Association between circulating soluble receptor for advanced glycation end products and atherosclerosis: observations from the Dallas Heart Study.

1 reference

12 December 2020

Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension.

1 reference

12 December 2020

A new equation to estimate glomerular filtration rate

1 reference

12 December 2020

Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases

1 reference

12 December 2020

Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins

1 reference

12 December 2020

Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans

1 reference

12 December 2020

The structure of haplotype blocks in the human genome

1 reference

12 December 2020

Increased serum endogenous secretory receptor for advanced glycation end-product (esRAGE) levels in type 2 diabetic patients with decreased renal function

1 reference

12 December 2020

Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes.

1 reference

12 December 2020

Soluble RAGE, diabetic nephropathy and genetic variability in theAGERgene

1 reference

12 December 2020

The effects of valsartan on the accumulation of circulating and renal advanced glycation end products in experimental diabetes.

1 reference

12 December 2020

Diabetic nephropathy is associated with low-grade inflammation in Type 1 diabetic patients

1 reference

12 December 2020

RAGE: therapeutic target and biomarker of the inflammatory response--the evidence mounts

1 reference

12 December 2020

Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury

1 reference

12 December 2020

Enhanced expression of receptor for advanced glycation end products in chronic kidney disease

1 reference

12 December 2020

Low circulating endogenous secretory receptor for AGEs predicts cardiovascular mortality in patients with end-stage renal disease

1 reference

12 December 2020

RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy

1 reference

12 December 2020

Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy.

1 reference

12 December 2020

Metabolic phenotypes, vascular complications, and premature deaths in a population of 4,197 patients with type 1 diabetes

1 reference

12 December 2020

Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis

1 reference

12 December 2020

Increased serum concentrations of soluble receptor for advanced glycation endproducts in patients with type 1 diabetes

1 reference

12 December 2020

The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes

1 reference

12 December 2020

Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes

1 reference

12 December 2020

Strengthening causal inference in cardiovascular epidemiology through Mendelian randomization

1 reference

12 December 2020

Advanced glycation end products and their circulating receptors and level of kidney function in older community-dwelling women

1 reference

12 December 2020

Blot hybridisation analysis of genomic DNA

1 reference

12 December 2020

Levels of soluble receptor for AGE are cross-sectionally associated with cardiovascular disease in type 1 diabetes, and this association is partially mediated by endothelial and renal dysfunction and by low-grade inflammation: the EURODIAB Prospectiv

1 reference

12 December 2020

Resolved: normal glomeruli filter nephrotic levels of albumin

1 reference

12 December 2020

Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease

1 reference

12 December 2020

Higher plasma soluble Receptor for Advanced Glycation End Products (sRAGE) levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study

1 reference

12 December 2020

Actual and actuarial probabilities of competing risks: apples and lemons.

1 reference

12 December 2020